跳至主要内容
临床试验/NCT04589286
NCT04589286已完成不适用

Phase II Study of Digital Life Coaching in Multiple Myeloma Patients Undergoing Stem Cell Transplantation

University of California, San Francisco2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年12月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Comparison of patients with >=1 benzodiazepine and Z-class (B/Z) prescriptions (versus < 1 B/Z prescriptions)

研究概览

简要总结

Autologous stem cell transplantation (SCT) is the standard of care for fit multiple myeloma (MM) patients; however, the first 100 days after SCT are marked by extensive life disruptions. We have found a 56% relative increase in the use of high-risk benzodiazepine and Z-class (B/Z) drugs for anxiety and insomnia among MM patients during this period. Digital life coaching (DLC), whereby trained coaches work longitudinally with patients through phone calls and text messages to accomplish personal goals, may be able to target anxiety and insomnia in a more integrative manner. This study will investigate whether peri-SCT DLC can lower B/Z usage and improve patient-reported well-being.

详细描述

This is a single-center, Phase II randomized study of MM patients comparing 16 weeks of DLC access versus quasi-usual care (quasi-usual because both arms will receive generic wellness-related electronic handouts alongside requests for patient-reported outcome (PRO) assessments).

Primary Objective:

To evaluate DLC's impact on B/Z drug usage (excluding lorazepam prescribed for chemotherapy-induced nausea/vomiting, or CINV)

Secondary Objectives:

  1. To evaluate DLC's impact on patient-reported general quality of life every 1-2 weeks
  2. To evaluate DLC's impact on patient-reported psychosocial distress every 1-2 weeks
  3. To evaluate DLC's impact on patient-reported insomnia every 1-2 weeks

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of one of the following (all referred to as multiple myeloma (MM) for the purposes of this protocol):
  • Multiple myeloma (ICD-10 code: C90.0)
  • Extramedullary plasmacytoma (ICD-10 code: C90.2)
  • Planned receipt of autologous stem cell transplantation (SCT) at University of California, San Francisco (UCSF)
  • Patients undergoing outpatient SCT will be eligible
  • Patients who received chemomobilization will be eligible
  • Ability to understand a written informed consent form (ICF) document, and the willingness to sign the ICF document

排除标准

  • Age < 18 years
  • SCT as salvage therapy
  • Patient-assessed lack of sufficient English proficiency
  • Lack of ownership of a personal smartphone

结局指标

主要结局

Comparison of patients with >=1 benzodiazepine and Z-class (B/Z) prescriptions (versus < 1 B/Z prescriptions)

时间窗: Up to 6 months

Proportions of patients with \>=1 B/Z prescription versus \<1 B/Z prescriptions will be compared between arms using chi-square analyses. Participants will be stratified on B/Z usage over time into 3 groups arms based on B/Z-naïve status (i.e., no B/Z usage at time of study enrollment), baseline psychosocial distress, defined as an National Comprehensive Caner Network (NCCN) Distress Thermometer (DT) score of 4 or higher, and baseline insomnia, defined as a Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance short form (SF) 4 item (4a) standardized score of 57 or higher.

Estimate change in B/Z usage

时间窗: Up to 6 months

Estimations or differences in changes over time by study group will be performed via a post-estimation test using one-sided t-tests at each assessment. To control the family wise error rate at alpha level of 0.05, the Bonferroni method will be used.

Number of participants with a missing NCCN Distress Thermometer (DT) assessment

时间窗: Up to 6 months

Sensitivity analyses for missing data will be performed on participants with missing NCCN DT Assessments

Number of participants with a missing PROMIS Sleep Disturbance SF-4a inventory

时间窗: Up to 6 months

Sensitivity analyses for missing data will be performed on participants with missing PROMIS Sleep Disturbance SF-4a inventories.

Number of participants with a missing Patient Reported Outcome Measurement Information System (PROMIS) Global Health (GH) assessment

时间窗: Up to 6 months

Sensitivity analyses for missing data will be performed on participants with missing PROMIS Global Health assessments

次要结局

  • Change in NCCN Distress Thermometer (DT) Scores(Up to 6 months)
  • Change in PROMIS 4-item Sleep Disturbance Short Form (SF-4a) Scores(Up to 6 months)
  • Change in PROMIS Global Health (GH) Scale Scores(Up to 6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验